Tyson Foods Inc's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Sep 27, 2025 · FY), Tyson Foods Inc reported revenue of $54.4B (+2.1% year on year) and net income of $507.0M (-38.3% year on year).
| Line item | Sep 27, 2025 · FY | Sep 28, 2024 · FY | Sep 30, 2023 · FY | Oct 1, 2022 · FY |
|---|---|---|---|---|
| Sales | $54.4B | $53.3B | $52.9B | $53.3B |
| Cost of Sales | $50.9B | $49.7B | $50.3B | $46.6B |
| Gross Profit | $3.6B | $3.6B | $2.6B | $6.7B |
| Selling, General and Administrative | $2.1B | $2.2B | $2.2B | $2.3B |
| Goodwill, Impairment Loss | $343.0M | $0 | $781.0M | — |
| Operating Income (Loss) | $1.1B | $1.4B | ($395.0M) | $4.4B |
| Interest income | ($73.0M) | ($89.0M) | ($30.0M) | ($17.0M) |
| Interest expense | $449.0M | $481.0M | $355.0M | $365.0M |
| Other, net | ($47.0M) | ($75.0M) | ($42.0M) | ($87.0M) |
| Total Other (Income) Expense | $329.0M | $317.0M | $283.0M | $261.0M |
| Income before Income Taxes | $769.0M | $1.1B | ($678.0M) | $4.1B |
| Income Tax Expense | $262.0M | $270.0M | ($29.0M) | $900.0M |
| Net Income | $507.0M | $822.0M | ($649.0M) | $3.2B |
| Less: Net Income Attributable to Noncontrolling Interests | $33.0M | $22.0M | ($1.0M) | $11.0M |
| Net Income Attributable to Tyson | $474.0M | $800.0M | ($648.0M) | $3.2B |
| Basic, Shares | 355.0M | 354.0M | 354.0M | 360.0M |
| Diluted, Shares | 357.0M | 356.0M | 284.0M | 363.0M |
| Basic (USD per share) | $2.59 | $4.37 | -$3.55 | $17.43 |
| Diluted (USD per share) | $1.33 | $2.25 | -$1.87 | $8.92 |
| Line item | Jun 27, 2026 · Q3 | Mar 28, 2026 · Q2 | Dec 27, 2025 · Q1 | Jun 28, 2025 · Q3 |
|---|---|---|---|---|
| Revenues | $13.9B | $13.7B | $14.3B | $13.9B |
| Cost of Sales | $12.9B | $12.7B | $13.5B | $12.7B |
| Gross Profit | $921.0M | $962.0M | $808.0M | $1.1B |
| Selling, General and Administrative | $559.0M | $527.0M | $506.0M | $538.0M |
| Operating Income | $362.0M | $435.0M | $302.0M | $260.0M |
| Interest income | ($6.0M) | ($8.0M) | ($13.0M) | ($15.0M) |
| Interest Expense, Nonoperating | $98.0M | $97.0M | $104.0M | $113.0M |
| Other, net | $4.0M | ($13.0M) | $84.0M | ($31.0M) |
| Total Other (Income) Expense | $96.0M | $76.0M | $175.0M | $67.0M |
| Income before Income Taxes | $266.0M | $359.0M | $127.0M | $193.0M |
| Income Tax Expense | $80.0M | $95.0M | $37.0M | $124.0M |
| Net Income | $186.0M | $264.0M | $90.0M | $69.0M |
| Less: Net Income Attributable to Noncontrolling Interests | $4.0M | $4.0M | $5.0M | $8.0M |
| Net Income Attributable to Tyson | $182.0M | $260.0M | $85.0M | $61.0M |
| Basic, Shares | 352.0M | 353.0M | 352.0M | 355.0M |
| Diluted, Shares | 355.0M | 354.0M | 354.0M | 357.0M |
| Basic (USD per share) | $1.01 | $1.43 | $0.47 | $0.34 |
| Diluted (USD per share) | $0.52 | $0.73 | $0.24 | $0.17 |
| Goodwill, Impairment Loss | $0 | — | — | $343.0M |
| Line item | Sep 27, 2025 · FY | Sep 28, 2024 · FY | Sep 30, 2023 · FY | Oct 1, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $1.2B | $1.7B | $573.0M | $1.0B |
| Accounts receivable, net | $2.5B | $2.4B | $2.5B | $2.6B |
| Inventories | $5.7B | $5.2B | $5.3B | $5.5B |
| Other current assets | $482.0M | $433.0M | $345.0M | $508.0M |
| Total Current Assets | $9.9B | $9.8B | $8.7B | $9.6B |
| Net Property, Plant and Equipment | $9.2B | $9.4B | $9.6B | $8.7B |
| Goodwill, net | $9.5B | $9.8B | $9.9B | $10.5B |
| Intangible Assets, net | $5.6B | $5.9B | $6.1B | $6.3B |
| Other Assets | $2.4B | $2.2B | $1.9B | $1.7B |
| Total Assets | $36.7B | $37.1B | $36.3B | $36.8B |
| Current debt | $909.0M | $74.0M | $1.9B | $459.0M |
| Accounts payable | $2.6B | $2.4B | $2.6B | $2.5B |
| Other current liabilities | $2.9B | $2.3B | $2.0B | $2.4B |
| Total Current Liabilities | $6.4B | $4.8B | $6.5B | $5.3B |
| Total long-term debt | $7.9B | $9.7B | $7.6B | $7.9B |
| Deferred Income Taxes | $2.2B | $2.3B | $2.3B | $2.5B |
| Other Liabilities | $1.9B | $1.8B | $1.6B | $1.4B |
| Common stock ($0.10 par value): | $45.0M | $45.0M | $45.0M | $45.0M |
| Capital in excess of par value | $4.7B | $4.6B | $4.6B | $4.6B |
| Retained earnings | $18.6B | $18.9B | $18.8B | $20.1B |
| Accumulated other comprehensive gain (loss) | ($191.0M) | ($184.0M) | ($260.0M) | ($297.0M) |
| Treasury stock, at cost – 88 million shares at October 1, 2022 and 83 million shares at October 2, 2021 | -5.1B | -4.9B | -5.0B | -4.7B |
| Total Tyson Shareholders’ Equity | $18.1B | $18.4B | $18.1B | $19.7B |
| Noncontrolling Interests | $142.0M | $124.0M | $122.0M | $109.0M |
| Total Shareholders’ Equity | $18.2B | $18.5B | $18.3B | $19.8B |
| Total Liabilities and Shareholders’ Equity | $36.7B | $37.1B | $36.3B | $36.8B |
| Line item | Jun 27, 2026 | Mar 28, 2026 | Dec 27, 2025 | Jun 28, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $740.0M | $500.0M | $1.3B | $1.5B |
| Accounts receivable, net | $2.5B | $2.4B | $2.4B | $2.5B |
| Inventories | $5.8B | $5.5B | $5.4B | $5.4B |
| Other current assets | $425.0M | $497.0M | $399.0M | $422.0M |
| Total Current Assets | $9.5B | $8.9B | $9.5B | $9.9B |
| Net Property, Plant and Equipment | $8.8B | $8.9B | $9.1B | $9.1B |
| Goodwill | $9.5B | $9.5B | $9.5B | $9.5B |
| Intangible Assets, net | $5.5B | $5.5B | $5.6B | $5.7B |
| Other Assets | $2.4B | $2.4B | $2.4B | $2.4B |
| Total Assets | $35.6B | $35.2B | $36.0B | $36.5B |
| Current debt | $1.4B | $141.0M | $909.0M | $886.0M |
| Accounts payable | $2.8B | $2.5B | $2.7B | $2.4B |
| Other current liabilities | $2.4B | $2.2B | $2.6B | $2.4B |
| Total Current Liabilities | $6.6B | $4.8B | $6.2B | $5.7B |
| Long-Term Debt | $6.6B | $7.9B | $7.5B | $8.2B |
| Deferred Income Taxes | $2.2B | $2.2B | $2.2B | $2.2B |
| Other Liabilities | $2.0B | $2.0B | $2.0B | $1.9B |
| Common stock ($0.10 par value): | $45.0M | $45.0M | $45.0M | $45.0M |
| Capital in excess of par value | $4.7B | $4.7B | $4.7B | $4.7B |
| Retained earnings | $18.6B | $18.6B | $18.6B | $18.8B |
| Accumulated other comprehensive income (loss) | ($168.0M) | ($152.0M) | ($143.0M) | ($195.0M) |
| Treasury stock, at cost – 96 million shares at June 27, 2026 and 95 million shares at September 27, 2025 | -5.2B | -5.2B | -5.1B | -4.9B |
| Total Tyson Shareholders’ Equity | $18.1B | $18.1B | $18.0B | $18.3B |
| Noncontrolling Interests | $106.0M | $103.0M | $140.0M | $130.0M |
| Total Shareholders’ Equity | $18.2B | $18.2B | $18.2B | $18.5B |
| Total Liabilities and Shareholders’ Equity | $35.6B | $35.2B | $36.0B | $36.5B |
| Line item | Sep 27, 2025 · FY | Sep 28, 2024 · FY | Sep 30, 2023 · FY | Oct 1, 2022 · FY |
|---|---|---|---|---|
| Net Income | $507.0M | $822.0M | ($649.0M) | $3.2B |
| Depreciation | $1.1B | $1.2B | $1.1B | $945.0M |
| Amortization | $268.0M | $241.0M | $239.0M | $257.0M |
| Deferred income taxes | ($76.0M) | ($45.0M) | ($183.0M) | $264.0M |
| Gain on Sale of Property, Plant, and Equipment | ($107.0M) | — | — | — |
| Other Asset Impairment Charges | $126.0M | $131.0M | $101.0M | — |
| Stock-based compensation expense | $100.0M | $101.0M | $61.0M | $93.0M |
| Other, net | $7.0M | ($43.0M) | $115.0M | ($51.0M) |
| Increase (Decrease) in Accounts Receivable | $121.0M | ($59.0M) | ($136.0M) | $176.0M |
| Increase (Decrease) in Inventories | $449.0M | ($153.0M) | ($175.0M) | $1.2B |
| Increase (Decrease) in Accounts Payable | $184.0M | ($205.0M) | $47.0M | $302.0M |
| Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable | $7.0M | $89.0M | $108.0M | ($580.0M) |
| Increase (Decrease) in Other Operating Assets and Liabilities, Net | ($273.0M) | ($128.0M) | $279.0M | $442.0M |
| Cash Provided by Operating Activities | $2.2B | $2.6B | $1.8B | $2.7B |
| Additions to property, plant and equipment | ($978.0M) | ($1.1B) | ($1.9B) | ($1.9B) |
| Purchases of marketable securities | ($66.0M) | ($38.0M) | ($34.0M) | ($35.0M) |
| Proceeds from sale of marketable securities | $62.0M | $35.0M | $32.0M | $34.0M |
| Proceeds from Sale of Property, Plant, and Equipment | $252.0M | — | — | — |
| Acquisitions, net of cash acquired | $0 | $0 | ($262.0M) | — |
| Proceeds from sale of businesses | $0 | $174.0M | $0 | $0 |
| Payments to Acquire Equity Method Investments | ($11.0M) | ($29.0M) | ($115.0M) | ($177.0M) |
| Other, net | $76.0M | $102.0M | $19.0M | $130.0M |
| Cash Used for Investing Activities | ($665.0M) | ($888.0M) | ($2.3B) | ($1.9B) |
| Proceeds from issuance of debt | $175.0M | $2.4B | $1.1B | $103.0M |
| Repayments on debt | $1.3B | $1.6B | $603.0M | $1.2B |
| Proceeds from Issuance of Commercial Paper | $0 | $1.7B | $7.7B | $0 |
| Repayments of Commercial Paper | $0 | $2.3B | $7.1B | $0 |
| Purchases of Tyson Class A common stock | ($196.0M) | ($49.0M) | ($354.0M) | ($702.0M) |
| Dividends | ($697.0M) | ($684.0M) | ($670.0M) | ($653.0M) |
| Stock options exercised | $21.0M | $14.0M | $11.0M | $126.0M |
| Other, net | ($18.0M) | ($45.0M) | ($16.0M) | ($6.0M) |
| Cash Used for Financing Activities | ($2.0B) | ($581.0M) | $88.0M | ($2.3B) |
| Payments for Repurchase of Common Stock | ($196.0M) | ($49.0M) | ($354.0M) | ($702.0M) |
| Effective Income Tax Rate Reconciliation, Net Unrecognized Tax Benefits, Percent | 1.2% | — | — | — |
| Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Beginning Balance | $1.7B | $1.7B | $573.0M | $1.0B |
| Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Ending Balance | $1.2B | $1.7B | $573.0M | — |
| Goodwill, Impairment Loss | $343.0M | $0 | $781.0M | — |
| Effect of Exchange Rate on Cash | ($1.0M) | $23.0M | $1.0M | ($35.0M) |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | ($488.0M) | $1.1B | ($458.0M) | ($1.6B) |
| Restricted Cash | $0 | $0 | $0 | $0 |
| Cash and cash equivalents | $1.2B | $1.7B | $573.0M | $1.0B |
| Line item | Jun 27, 2026 · YTD | Mar 28, 2026 · YTD | Dec 27, 2025 · Q1 | Jun 28, 2025 · YTD |
|---|---|---|---|---|
| Additions to property, plant and equipment | ($556.0M) | ($397.0M) | ($252.0M) | ($691.0M) |
| Purchases of marketable securities | ($49.0M) | ($36.0M) | ($21.0M) | ($50.0M) |
| Proceeds from sale of marketable securities | $77.0M | $35.0M | $20.0M | $47.0M |
| Proceeds from Sale of Property, Plant, and Equipment | $44.0M | $44.0M | $42.0M | $252.0M |
| Other, net | $64.0M | $55.0M | $28.0M | $42.0M |
| Cash Used for Investing Activities | ($420.0M) | ($299.0M) | ($183.0M) | ($405.0M) |
| Net Income | $540.0M | $354.0M | $90.0M | $449.0M |
| Depreciation and amortization | $1.1B | $726.0M | $376.0M | $1.0B |
| Deferred income taxes | $34.0M | $12.0M | $0 | ($61.0M) |
| Gain on Sale of Property, Plant, and Equipment | $0 | — | — | $107.0M |
| Goodwill, Impairment Loss | $0 | — | — | $343.0M |
| Other, net | $230.0M | $193.0M | $163.0M | $158.0M |
| Net changes in operating assets and liabilities | ($390.0M) | ($456.0M) | $313.0M | ($191.0M) |
| Cash Provided by Operating Activities | $1.5B | $829.0M | $942.0M | $1.6B |
| Proceeds from issuance of debt | $564.0M | $534.0M | $23.0M | $63.0M |
| Repayments of Debt and Lease Obligation | $1.4B | $1.3B | $509.0M | $876.0M |
| Repayments of Commercial Paper | ($945.0M) | ($915.0M) | — | $0 |
| Purchases of Tyson Class A common stock | ($123.0M) | ($92.0M) | ($47.0M) | ($42.0M) |
| Dividends | ($529.0M) | ($353.0M) | ($177.0M) | ($524.0M) |
| Stock options exercised | $26.0M | $15.0M | $6.0M | $20.0M |
| Other, net | ($49.0M) | ($55.0M) | ($14.0M) | ($18.0M) |
| Cash Used for Financing Activities | ($1.5B) | ($1.3B) | ($718.0M) | ($1.4B) |
| Payments for Repurchase of Common Stock | ($123.0M) | ($92.0M) | ($47.0M) | ($42.0M) |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $740.0M | $500.0M | $1.3B | $1.5B |
| Payments to Acquire Equity Method Investments | $0 | $0 | — | ($5.0M) |
| Proceeds from issuance of commercial paper | $945.0M | $945.0M | — | $0 |
| Cash and cash equivalents | $740.0M | $500.0M | $1.3B | $1.5B |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | ($489.0M) | ($729.0M) | $49.0M | ($170.0M) |
| Restricted Cash | $0 | $0 | $0 | $0 |
| Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | $8.0M | $8.0M | $8.0M | ($8.0M) |
| Other Noncash Income (Expense) | $230.0M | $193.0M | $163.0M | $158.0M |
Tyson Foods Inc score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.